|  | Final analysis set (N = 486) | ||
---|---|---|---|---|
 |  | LS mean | 95 % CI | P value |
Follow-up | 6 months | −0.00 | −0.53 to 0.53 | – |
 | 12 months | 0.76 | 0.22–1.30 | – |
 | 18 months | 0.92 | 0.36–1.48 | – |
 | 24 months | 1.29 | 0.71–1.86 | – |
 | 6–12 months | −0.76 | −1.04 to −0.48 | <.0001 |
 | 6–18 months | −0.92 | −1.26 to −0.58 | <.0001 |
 | 6–24 months | −1.29 | −1.65 to −0.93 | <.0001 |
 | 12–18 months | −0.16 | −0.46 to 0.14 | .2895 |
 | 12–24 months | −0.53 | −0.88 to −0.18 | .0033 |
 | 18–24 months | −0.37 | −0.67 to −0.07 | .0172 |
Prior chemotherapies | Yes | 1.54 | 0.96–2.12 | – |
 | No | −0.06 | −0.64 to 0.53 | – |
 | Yes–No | 1.60 | 1.05–2.14 | <.0001 |
Age group | >60 years | 1.01 | 0.38–1.64 | – |
 | ≤60 years | 0.47 | −0.07–1.01 | – |
 | >60 years – ≤60 years | 0.54 | −0.03 to 1.10 | .0613 |
Mastectomy | Yes | 1.20 | 0.85–1.55 | – |
 | No | 0.29 | −0.68 to 1.25 | – |
 | Yes–No | 0.91 | −0.12 to 1.94 | .0823 |
Axillary lymph-node dissection | Yes | 0.48 | −0.10 to 1.06 | – |
 | No | 1.01 | 0.36–1.65 | – |
 | Yes–No | −0.53 | −1.20–0.14 | .1233 |